Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0867-2010

Variant II Turbo Hemoglobin A1c Program, model number 270 2417, manufactured by Bio-Rad Laboratories, Inc...

Bio-Rad Laboratories Inc. / initiated 2009-10-12 / Terminated

Bio-Rad Laboratories Inc began a recall of Variant II Turbo Hemoglobin A1c Program, model number 270 2417, manufactured by Bio-Rad Laboratories, Inc, Hercules, CA. Intended Use: For the percent... on . The reason FDA records is "Product update kit CD rom will not upload. As a result, the device cannot be run". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0867-2010
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Bio-Rad Laboratories Inc.
Product
Variant II Turbo Hemoglobin A1c Program, model number 270 2417, manufactured by Bio-Rad Laboratories, Inc, Hercules, CA. Intended Use: For the percent determination of hemoglobin A1c in human whole blood using ion-exchange high-performance liquid chromatography (HPLC).
Product code
LCP Assay, Glycosylated Hemoglobin
Reason for recall
Product update kit CD rom will not upload. As a result, the device cannot be run.
FDA root cause
Other
Action
The firm initiated this action on 10/12/2009. Consignees were contacted by phone with a fax follow up. Subsidiaries, as well as consignees that received the product, were provided with a Medical Device Correction notice, dated October 13, 2009, and response form. Each subsidiary will contact customers. The letter asks customers to destroy the affected lot included with their reorder packs and replace them with the lot number that's enclosed. Customers are to complete the Customer Medical Device Correction Response Form and fax it to Bio-Rad CSD Regulatory Affairs Department at the number provided. Questions should be directed to customers' regional Bio-Rad office.
Quantity in commerce
21 kits
Distribution
Worldwide Distribution -- USA, Hong Kong, and New Zealand.
Product codes and lots
Lot No. 70291520.